Skip to content
  • Home
  • US Market Updates
  • Indicators
    • Impulse Master
    • Cycle Trader
    • GANN Levels
    • Subscribe
  • Education
    • Beginners Video Course
    • Intermediate Video Course
      • Syllabus of the Course
    • Trading Like A Pro Video Course
    • Video Lesson of the Week
  • Chat Room
  • Pricing
  • FAQ
  • Home
  • US Market Updates
  • Indicators
    • Impulse Master
    • Cycle Trader
    • GANN Levels
    • Subscribe
  • Education
    • Beginners Video Course
    • Intermediate Video Course
      • Syllabus of the Course
    • Trading Like A Pro Video Course
    • Video Lesson of the Week
  • Chat Room
  • Pricing
  • FAQ
  • My Account
  • Login
CastAway Trader - Premium Trading Chat Room
CastAway Trader Predict the Next Market Move

Subscription: Value Stocks

ABBV is a great company but the stock does not look having bottomed

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products.

I count the top made by ABBV at $125.86 in January 2018 as the top of the wave ( 3 ) up, the strongest part of the rally. In full accordance to the Five Wave Up fractal, a corrective looking decline followed. That wave ( 4 ) down is shaped as so called “triple three”. This is a complex correction that is combined of three A-B-C structures. It had great chances to bottom at $77.50 in November 2018. Back then it completed two A-B-C structures. However a new lower low (75.77) made in February 2019 killed that possibility. That drop should be counted as the first leg down in wave A of the third A-B-C structure. That implies the move up we are getting now is only a corrective pullback in wave B up and that bounce should be followed bu another impulsive looking drop in wave C down.

If we apply Fibonacci retracement ratios to completed rally in wave ( 3 ) up we may get tow important levels: $71.95 (61.8%) and $64.14 (76.4%). As soon as that corrective rally in wave B up is completed we will be able to apply extensions of the wave A down from the top of that wave B to make more precise estimations of the potential bottom of the wave C down.

ABBV - Weekly chart updated on 4/6/2019

weekly

Financial Strength

The company has great profitability ratios but is has a large debt. Debt is considered normal when it does not exceed EBITDA by more that x 2.5 times. ABBV has DEBT exceeding EBITDA by x 4.9 times! It is traded with a favorable valuation with Price-to-Free-Cash-Flow at x 10.

Operating Margin

19%

Net
Margin

17%

Return on Capital

208%

Price-to-Free-Cash-Flow

x 10

Debt-to-EBITDA

x 4.9

Dividend
Yield

4.7%

Disclaimer

© 2025 CastAway Trader • Built with GeneratePress